Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.
暂无分享,去创建一个
G. Beck | J. Moss | K. Brown | J. Ryu | J. Maurer | E. Olson | J. Chapman | S. Ruoss | S. Sherer | J. McMahan | Jar‐chi Lee | Geraldine R. Finlay | G. Finlay
[1] G. Beck,et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. , 2006, American journal of respiratory and critical care medicine.
[2] A. Geha,et al. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[3] G. Patterson,et al. Lung transplantation for lymphangioleiomyomatosis. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[4] D. Johnson,et al. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. , 2000, Respiratory medicine.
[5] J. Lacronique,et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). , 1999, Medicine.
[6] R. Speich,et al. Lung transplantation for lymphangioleiomyomatosis. , 1996, The New England journal of medicine.
[7] John L. Hankinson,et al. Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[8] A. Miller,et al. Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.